vs
AMICUS THERAPEUTICS, INC.（FOLD）与Riley Exploration Permian, Inc.（REPX）财务数据对比。点击上方公司名可切换其他公司
AMICUS THERAPEUTICS, INC.的季度营收约是Riley Exploration Permian, Inc.的1.6倍（$185.2M vs $113.9M），AMICUS THERAPEUTICS, INC.净利率更高（0.9% vs -61.8%，领先62.8%），AMICUS THERAPEUTICS, INC.同比增速更快（23.7% vs 11.2%），Riley Exploration Permian, Inc.自由现金流更多（$24.6M vs $16.0M），过去两年AMICUS THERAPEUTICS, INC.的营收复合增速更高（29.5% vs 3.9%）
Amicus Therapeutics是总部位于美国宾夕法尼亚州费城的生物制药上市企业，2007年在纳斯达克挂牌上市，股票代码为FOLD。上市前，公司曾获得Radius Ventures、迦南合伙人、恩颐投资等多家风险投资机构的资金支持，专注于生物医药领域的研发与商业化布局。
Riley Exploration Permian, Inc.是一家独立能源企业，专注于美国得克萨斯州与新墨西哥州境内的二叠纪盆地，开展原油、天然气及天然气凝析液的勘探、开发与生产业务，主打低成本陆上储备开发，为北美市场供应稳定能源产品。
FOLD vs REPX — 直观对比
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $185.2M | $113.9M |
| 净利润 | $1.7M | $-70.4M |
| 毛利率 | 85.7% | — |
| 营业利润率 | 8.6% | 38.3% |
| 净利率 | 0.9% | -61.8% |
| 营收同比 | 23.7% | 11.2% |
| 净利润同比 | -88.5% | — |
| 每股收益（稀释后） | $0.00 | $-3.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q1 26 | — | $113.9M | ||
| Q4 25 | $185.2M | $97.3M | ||
| Q3 25 | $169.1M | $106.9M | ||
| Q2 25 | $154.7M | $85.4M | ||
| Q1 25 | $125.2M | $102.5M | ||
| Q4 24 | $149.7M | $102.7M | ||
| Q3 24 | $141.5M | $102.3M | ||
| Q2 24 | $126.7M | $105.4M |
| Q1 26 | — | $-70.4M | ||
| Q4 25 | $1.7M | — | ||
| Q3 25 | $17.3M | $16.3M | ||
| Q2 25 | $-24.4M | $30.5M | ||
| Q1 25 | $-21.7M | $28.6M | ||
| Q4 24 | $14.7M | — | ||
| Q3 24 | $-6.7M | $25.7M | ||
| Q2 24 | $-15.7M | $33.5M |
| Q1 26 | — | — | ||
| Q4 25 | 85.7% | — | ||
| Q3 25 | 88.5% | — | ||
| Q2 25 | 90.2% | — | ||
| Q1 25 | 90.7% | — | ||
| Q4 24 | 90.1% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 91.1% | — |
| Q1 26 | — | 38.3% | ||
| Q4 25 | 8.6% | 26.9% | ||
| Q3 25 | 20.3% | 27.0% | ||
| Q2 25 | -6.1% | 33.7% | ||
| Q1 25 | -6.3% | 48.3% | ||
| Q4 24 | 10.7% | 31.2% | ||
| Q3 24 | 15.3% | 17.1% | ||
| Q2 24 | 11.8% | 50.9% |
| Q1 26 | — | -61.8% | ||
| Q4 25 | 0.9% | — | ||
| Q3 25 | 10.2% | 15.3% | ||
| Q2 25 | -15.8% | 35.7% | ||
| Q1 25 | -17.3% | 27.9% | ||
| Q4 24 | 9.8% | — | ||
| Q3 24 | -4.8% | 25.1% | ||
| Q2 24 | -12.4% | 31.8% |
| Q1 26 | — | $-3.38 | ||
| Q4 25 | $0.00 | $4.02 | ||
| Q3 25 | $0.06 | $0.77 | ||
| Q2 25 | $-0.08 | $1.44 | ||
| Q1 25 | $-0.07 | $1.36 | ||
| Q4 24 | $0.05 | $0.52 | ||
| Q3 24 | $-0.02 | $1.21 | ||
| Q2 24 | $-0.05 | $1.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $293.5M | — |
| 总债务越低越好 | $392.7M | $240.7M |
| 股东权益账面价值 | $274.2M | $553.4M |
| 总资产 | $949.9M | $1.2B |
| 负债/权益比越低杠杆越低 | 1.43× | 0.43× |
8季度趋势，按日历期对齐
| Q1 26 | — | — | ||
| Q4 25 | $293.5M | — | ||
| Q3 25 | $263.8M | — | ||
| Q2 25 | $231.0M | — | ||
| Q1 25 | $250.6M | — | ||
| Q4 24 | $249.9M | — | ||
| Q3 24 | $249.8M | — | ||
| Q2 24 | $260.1M | — |
| Q1 26 | — | $240.7M | ||
| Q4 25 | $392.7M | $247.9M | ||
| Q3 25 | $392.0M | $367.0M | ||
| Q2 25 | $391.3M | $275.2M | ||
| Q1 25 | $390.7M | $249.3M | ||
| Q4 24 | $390.1M | $269.5M | ||
| Q3 24 | $389.5M | $288.6M | ||
| Q2 24 | $388.9M | $322.7M |
| Q1 26 | — | $553.4M | ||
| Q4 25 | $274.2M | $634.2M | ||
| Q3 25 | $230.4M | $566.5M | ||
| Q2 25 | $204.3M | $556.9M | ||
| Q1 25 | $193.6M | $532.4M | ||
| Q4 24 | $194.0M | $510.6M | ||
| Q3 24 | $178.8M | $507.4M | ||
| Q2 24 | $132.5M | $489.0M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $949.9M | $1.2B | ||
| Q3 25 | $868.8M | $1.2B | ||
| Q2 25 | $815.3M | $1.0B | ||
| Q1 25 | $789.8M | $994.9M | ||
| Q4 24 | $785.0M | $993.5M | ||
| Q3 24 | $786.6M | $997.9M | ||
| Q2 24 | $749.5M | $1.0B |
| Q1 26 | — | 0.43× | ||
| Q4 25 | 1.43× | 0.39× | ||
| Q3 25 | 1.70× | 0.65× | ||
| Q2 25 | 1.92× | 0.49× | ||
| Q1 25 | 2.02× | 0.47× | ||
| Q4 24 | 2.01× | 0.53× | ||
| Q3 24 | 2.18× | 0.57× | ||
| Q2 24 | 2.93× | 0.66× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $16.3M | $47.2M |
| 自由现金流经营现金流 - 资本支出 | $16.0M | $24.6M |
| 自由现金流率自由现金流/营收 | 8.6% | 21.6% |
| 资本支出强度资本支出/营收 | 0.2% | 41.3% |
| 现金转化率经营现金流/净利润 | 9.62× | — |
| 过去12个月自由现金流最近4个季度 | $29.8M | — |
8季度趋势，按日历期对齐
| Q1 26 | — | $47.2M | ||
| Q4 25 | $16.3M | $64.9M | ||
| Q3 25 | $35.7M | $63.6M | ||
| Q2 25 | $-26.5M | $33.6M | ||
| Q1 25 | $7.8M | $50.4M | ||
| Q4 24 | $-3.9M | $66.4M | ||
| Q3 24 | $-23.0M | $72.1M | ||
| Q2 24 | $22.7M | $51.6M |
| Q1 26 | — | $24.6M | ||
| Q4 25 | $16.0M | — | ||
| Q3 25 | $35.3M | — | ||
| Q2 25 | $-28.9M | — | ||
| Q1 25 | $7.5M | — | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-23.3M | — | ||
| Q2 24 | $21.6M | — |
| Q1 26 | — | 21.6% | ||
| Q4 25 | 8.6% | — | ||
| Q3 25 | 20.9% | — | ||
| Q2 25 | -18.7% | — | ||
| Q1 25 | 6.0% | — | ||
| Q4 24 | -2.8% | — | ||
| Q3 24 | -16.5% | — | ||
| Q2 24 | 17.0% | — |
| Q1 26 | — | 41.3% | ||
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 1.6% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | 9.62× | — | ||
| Q3 25 | 2.06× | 3.90× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | — | 1.76× | ||
| Q4 24 | -0.27× | — | ||
| Q3 24 | — | 2.81× | ||
| Q2 24 | — | 1.54× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
REPX
暂无分部数据
